ILMN Illumina, Inc. - Common Stock
Acerca de Illumina, Inc. - Common Stock Descripción general de la empresa de Wikipedia
Illumina, Inc. es una compañía estadounidense fundada en abril de 1998 que desarrolla, fabrica y comercializa sistemas integrados para el análisis de variación genética y función biológica. En 2014 fue nombrada por MIT Technology Review como "la compañía más inteligente del mundo". Mediante el uso de su tecnología, Illumina proporciona una línea de productos y servicios que sirven a los mercados de secuenciación, genotipado y expresión génica. Esta tecnología ha conseguido reducir el coste de secuenciar el genoma humano desde $1.000.000 en 2007 a $4 000 en 2013. Sus clientes incluyen centros de investigación genómica, compañías farmacéuticas, instituciones académicas, organizaciones de investigación clínica y compañías biotecnológicas. Sus herramientas proporcionan a los investigadores la capacidad de realizar los tests genéticos necesarios para extraer información médica gracias a los avances en genómica y proteómica. Su sede se encuentra en San Diego, California.
Leer más
Illumina, Inc. es una compañía estadounidense fundada en abril de 1998 que desarrolla, fabrica y comercializa sistemas integrados para el análisis de variación genética y función biológica. En 2014 fue nombrada por MIT Technology Review como "la compañía más inteligente del mundo". Mediante el uso de su tecnología, Illumina proporciona una línea de productos y servicios que sirven a los mercados de secuenciación, genotipado y expresión génica. Esta tecnología ha conseguido reducir el coste de secuenciar el genoma humano desde $1.000.000 en 2007 a $4 000 en 2013. Sus clientes incluyen centros de investigación genómica, compañías farmacéuticas, instituciones académicas, organizaciones de investigación clínica y compañías biotecnológicas. Sus herramientas proporcionan a los investigadores la capacidad de realizar los tests genéticos necesarios para extraer información médica gracias a los avances en genómica y proteómica. Su sede se encuentra en San Diego, California.
Illumina comenzó a ofrecer servicios de genotipado de polimorfismo de nucleótido simple (SNP) en 2001 y lanzó su primer sistema, el Illumina BeadLab, en 2002. En 2007 la compañía adquirió Solexa, Inc.(tecnología de secuenciación del genoma de la Universidad de Cambridge). En 2007 Illumina vendía únicamente productos que estaban etiquetados como "solo uso para investigación"; a principios de 2010 Illumina obtuvo la aprobación de FDA para poder ser usado en test clínicos. Esto fue parte de la estrategia de la compañía para abrir su propio laboratorio CLIA l y para empezar a ofrecer test genéticos clínicos. En 2015 Illumina originó la compañía Grail que se centraba en test sanguíneos para detectar cáncer en torrente sanguíneo. La compañía está trabajando con pruebas experimentales de test sanguíneos con alrededor de 120 000 mujeres en los estados de Minnesota y Wisconsin, además de colaborar con la Mayo Clinic. La compañía Grail usa la tecnología de secuenciación de Illumina para realizar tests y lanzó tests en 2019 con un costo de 500$ por individuo.
Actualmente, esta empresa ofrece productos basados en microarrays y todo tipo de servicios relacionados con el análisis genético (como secuenciación, análisis de la expresión génica y análisis de proteínas).
## Disputa legal y separación de Grail Inc.
En septiembre de 2020, Illumina anunció su intención de adquirir Grail. La operación atrajo el interés de las autoridades de competencia y la Comisión Europea mostró preocupación ante la posibilidad de que la integración vertical entre ambas compañías pudiera tener efectos negativos en la competencia.
Illumina dio luz verde a la separación de Grail y comunicó su intención de repartir entre sus accionistas acciones de esa compañía como dividendo. La escisión debía cerrarse a finales de junio de 2024, y Illumina conservaría una participación del 14,5% en Grail.En junio se completó la separación de Grail, que pasó a ser conocida con un símbolo Nasdaq nuevo: GRAIL, Inc. Common Stock (GRAL).
Fuente: Wikipedia, CC BY-SA 4.0 · Ver en Wikipedia ↗
ILMN Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
ILMN Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
ILMN Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
- Compra fuerte 7 25,0%
- Compra 10 35,7%
- Mantener 8 28,6%
- Venta 2 7,1%
- Venta fuerte 1 3,6%
Precio objetivo a 12 meses
19 analistas · 2026-08-24Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 30 de junio de 2026 | $1.31 | $1.25 | 0.06% |
| 31 de marzo de 2026 | $1.15 | $1.08 | 0.07% |
| 31 de diciembre de 2025 | $1.15 | $1.08 | 0.07% |
| 30 de septiembre de 2025 | $1.34 | $1.19 | 0.15% |
| 30 de junio de 2025 | $1.19 | $1.03 | 0.16% |
| 31 de marzo de 2025 | $0.97 | $0.96 | 0.01% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| ILMN | $20.65B | 24.8 | -0.66% | 19.6% | 34.1% | 66.1% |
| TMO | $257.86B | 32.7 | 3.9% | 15.0% | 13.0% | — |
| DHR | $161.82B | 45.3 | 2.9% | 14.7% | 7.1% | 59.1% |
| A | $41.43B | 32.0 | 6.7% | 18.8% | 20.6% | — |
| IQV | $38.23B | 28.8 | 5.9% | 8.3% | 21.6% | — |
| WAT | $22.62B | 35.3 | 7.0% | 20.3% | 27.2% | — |
| MTD | $28.38B | 33.2 | 4.0% | 21.6% | -615.5% | 59.4% |
| WST | $19.81B | 40.5 | 6.2% | 16.1% | 16.2% | 35.9% |
| MEDP | $15.93B | 36.8 | 20.0% | 17.8% | 142.9% | — |
| CRL | $10.02B | -70.0 | -0.85% | -3.6% | -4.4% | — |
| TEM | — | -41.9 | 83.4% | -19.3% | -61.2% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 18
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.34B | $4.37B | $4.50B | $4.58B | $4.53B | $3.24B | $3.54B | $3.33B | $2.75B | $2.40B | $2.22B | $1.86B | |
| Cost of Revenue | $1.47B | $1.51B | $1.76B | $1.61B | $1.37B | $1.04B | $1.08B | $1.03B | $926M | $732M | $671M | $564M | |
| Gross Profit | $2.87B | $2.86B | $2.74B | $2.97B | $3.15B | $2.20B | $2.47B | $2.30B | $1.83B | $1.67B | $1.55B | $1.30B | |
| R&D Expense | $967M | $1.17B | $1.35B | $1.32B | $1.19B | $682M | $647M | $623M | $546M | $504M | $401M | $388M | |
| SG&A Expense | $1.09B | $1.09B | $1.61B | $1.30B | $2.09B | $941M | $835M | $794M | $674M | $584M | $516M | $466M | |
| Operating Expenses | $2.06B | $3.69B | $3.81B | $7.15B | $3.28B | $1.62B | $1.48B | $1.42B | $1.22B | $1.08B | $936M | $783M | |
| Operating Income | $807M | $-833M | $-1.07B | $-4.18B | $-123M | $580M | $985M | $883M | $606M | $587M | $613M | $515M | |
| Interest Expense | · | · | $77M | $26M | $61M | $49M | $52M | $57M | $37M | $33M | $43M | $42M | |
| Interest Income | $40M | $46M | $58M | $11M | $0 | $41M | $75M | $44M | $19M | $10M | $5M | $4M | |
| Other Non-op | $340M | $-292M | $-29M | $-142M | $1.07B | $284M | $110M | $24M | $455M | $-3M | $-8M | $-33M | |
| Pretax Income | $1.09B | $-1.18B | $-1.12B | $-4.34B | $884M | $856M | $1.12B | $894M | $1.04B | $561M | $583M | $449M | |
| Income Tax | $236M | $44M | $44M | $68M | $122M | $200M | $128M | $112M | $365M | $133M | $125M | $95M | |
| Net Income | $850M | $-1.22B | $-1.16B | $-4.40B | $762M | $656M | $1.00B | $826M | $726M | $463M | $462M | $353M | |
| EPS (Basic) | $5.47 | $-7.69 | $-7.34 | $-28.00 | $5.07 | $4.48 | $6.81 | $5.63 | $4.96 | $3.09 | $3.19 | $2.61 | |
| EPS (Diluted) | $5.45 | $-7.69 | $-7.34 | $-28.00 | $5.04 | $4.45 | $6.74 | $5.56 | $4.92 | $3.07 | $3.10 | $2.37 | |
| Shares (Basic) | 155,000,000 | 159,000,000 | 158,000,000 | 157,000,000 | 150,000,000 | 147,000,000 | 147,000,000 | 147,000,000 | 146,000,000 | 147,000,000 | 145,000,000 | 135,553,000 | |
| Shares (Diluted) | 156,000,000 | 159,000,000 | 158,000,000 | 157,000,000 | 151,000,000 | 148,000,000 | 149,000,000 | 149,000,000 | 148,000,000 | 148,000,000 | 149,000,000 | 148,977,000 | |
| EBITDA | $1.08B | $-479M | $-637M | $-3.79B | $128M | $767M | $1.17B | $1.06B | $762M | $729M | $613M | · |
Balance general 29
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | · | · | · | · | $1.14B | $1.23B | $735M | $769M | $636M | |
| Short-term Investments | $215M | $93M | $6M | $26M | $107M | $1.66B | $1.37B | $2.37B | $920M | $824M | $617M | $702M | |
| Receivables | $854M | $735M | $734M | $671M | $648M | $487M | $573M | $514M | $411M | $381M | $386M | $289M | |
| Inventory | $564M | $547M | $587M | $568M | $431M | $372M | $359M | $386M | $333M | $300M | $271M | $191M | |
| Prepaid Expense | $238M | $244M | $234M | $285M | $295M | $152M | $105M | $78M | $91M | $78M | $54M | $30M | |
| Current Assets | $3.29B | $2.75B | $2.61B | $3.56B | $2.71B | $4.48B | $4.45B | $4.49B | $2.98B | $2.32B | $2.10B | $1.89B | |
| PP&E (Net) | $759M | $815M | $1.01B | $1.09B | $1.02B | $922M | $889M | $1.07B | $931M | $713M | $343M | $265M | |
| PP&E (Gross) | $2.12B | $2.07B | $2.15B | $2.05B | $1.82B | $1.60B | $1.46B | $1.60B | $1.35B | $1.04B | $609M | $480M | |
| Accum. Depreciation | $1.36B | $1.25B | $1.14B | $962M | $796M | $678M | $568M | $521M | $416M | $327M | $267M | $215M | |
| Goodwill | $1.11B | $1.11B | $2.54B | $3.24B | $7.11B | $897M | $897M | $831M | $771M | $776M | $753M | $725M | |
| Intangibles | $210M | $295M | $2.99B | $3.29B | $3.25B | $142M | $145M | $185M | $175M | $243M | $274M | $314M | |
| Other Non-current Assets | $449M | $348M | $357M | $423M | $445M | $609M | $388M | $308M | $312M | $108M | $87M | $96M | |
| Total Assets | $6.64B | $6.30B | $10.11B | $12.25B | $15.22B | $7.58B | $7.32B | $6.96B | $5.26B | $4.28B | $3.69B | $3.34B | |
| Accounts Payable | $240M | $221M | $245M | $293M | $332M | $192M | $149M | $184M | $160M | $138M | $139M | $83M | |
| Accrued Liabilities | $846M | $827M | $1.32B | $1.23B | $761M | $541M | $516M | $513M | $432M | $342M | $387M | $335M | |
| Short-term Debt | $499M | $499M | $0 | $500M | $0 | · | · | · | · | · | · | · | |
| Current Liabilities | $1.58B | $1.55B | $1.57B | $2.77B | $1.09B | $1.24B | $665M | $1.80B | $746M | $705M | $610M | $722M | |
| Capital Leases | $486M | $554M | $687M | $744M | $774M | $671M | $695M | · | · | · | · | · | |
| Other Non-current Liabilities | $360M | $339M | $620M | $649M | $915M | $303M | $202M | $359M | $360M | $206M | $181M | $168M | |
| Long-term Debt | · | · | · | · | · | $1.18B | $1.14B | $2.00B | $1.19B | $1.06B | $1.09B | $1.29B | |
| Total Debt | $499M | $499M | $0 | $500M | · | $1.18B | $1.14B | $2.00B | $1.19B | $1.05B | $1.09B | · | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Paid-in Capital | $7.82B | $7.53B | $9.55B | $9.21B | $8.94B | $3.81B | $3.56B | $3.29B | $2.83B | $2.73B | $2.50B | $2.17B | |
| Retained Earnings | $-392M | $-1.24B | $-19M | $1.14B | $5.49B | $4.72B | $4.07B | $3.08B | $2.26B | $1.49B | $1.02B | $561M | |
| Treasury Stock | $4.70B | $3.93B | $3.79B | $3.75B | $3.70B | $3.85B | $3.02B | $2.62B | $2.34B | $2.02B | $1.67B | $1.27B | |
| AOCI | $-10M | $22M | $-1M | $3M | $17M | $2M | $5M | $-1M | $-1M | $-1M | $36.0K | $-1M | |
| Stockholders' Equity | $2.72B | $2.37B | $5.75B | $6.60B | $10.74B | $4.69B | $4.61B | $3.85B | $2.75B | $2.20B | $1.85B | $1.46B | |
| Liabilities + Equity | $6.64B | $6.30B | $10.11B | $12.25B | $15.22B | $7.58B | $7.32B | $6.96B | $5.26B | $4.28B | $3.69B | $3.34B | |
| Shares Outstanding | 201,000,000 | 200,000,000 | 199,000,000 | 198,000,000 | 197,000,000 | 195,000,000 | 147,000,000 | 147,000,000 | 147,000,000 | 146,000,000 | 146,584,000 | 143,629,000 |
Flujo de Efectivo 19
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $270M | $354M | $432M | $394M | $251M | $187M | $188M | $179M | $156M | $141M | $127M | $113M | |
| Stock-based Comp | $275M | $370M | $380M | $366M | $754M | $194M | $194M | $193M | $164M | $129M | $133M | $153M | |
| Deferred Tax | $119M | $-117M | $-34M | $-23M | $-76M | $117M | $5M | $-18M | $34M | $7M | $-45M | $-20M | |
| Amort. of Intangibles | $67M | $130M | $197M | $179M | $75M | $31M | $37M | $39M | $46M | $51M | $54M | $51M | |
| Restructuring | $47M | $16M | $52M | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | $-435M | $1.45B | $861M | $4.06B | $-1.15B | $-74M | $-338M | $-38M | $-205M | $-53M | · | · | |
| Operating Cash Flow | $1.08B | $837M | $478M | $392M | $545M | $1.08B | $1.05B | $1.14B | $875M | $779M | $786M | $501M | |
| CapEx | $148M | $128M | $195M | $286M | $208M | $189M | $209M | $296M | $310M | $260M | $143M | $106M | |
| Investing Cash Flow | $-55M | $-178M | $-231M | $-591M | $-1.07B | $-554M | $745M | $-1.81B | $-214M | $-515M | $-107M | $-407M | |
| Debt Issued | $495M | $1.24B | $0 | $991M | $988M | $0 | $0 | $735M | $5M | $5M | · | $1.13B | |
| Net Debt Issued | $495M | $1.24B | $0 | $991M | $988M | $0 | $0 | $735M | $5M | $5M | · | · | |
| Stock Issued | $44M | $56M | $67M | $63M | $60M | $61M | $59M | $46M | $71M | $47M | $72M | $96M | |
| Stock Repurchased | $742M | $116M | $0 | $0 | $0 | $736M | $324M | $201M | $251M | $249M | $274M | $237M | |
| Net Stock Activity | $-698M | $-60M | $67M | $63M | $60M | $-675M | $-265M | $-155M | $-180M | $-202M | $-202M | · | |
| Financing Cash Flow | $-744M | $-570M | $-1.21B | $1.00B | $-51M | $-766M | $-897M | $594M | $-176M | $-296M | $-545M | $-167M | |
| Net Change in Cash | $291M | $79M | $-963M | $779M | $-578M | $-232M | $898M | $-81M | $490M | $-34M | $133M | $-75M | |
| Taxes Paid | $73M | $105M | $65M | $122M | $233M | $119M | $164M | $99M | $149M | $60M | $17M | $18M | |
| Free Cash Flow | $931M | $709M | $283M | $106M | $337M | $891M | $842M | $846M | $565M | $427M | $517M | · | |
| Levered FCF | · | · | $203M | $80M | $284M | $853M | $796M | $796M | $541M | $402M | $484M | · |
Rentabilidad 8
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 66.1% | 65.4% | 60.9% | 64.8% | 69.7% | 68.0% | 69.6% | 69.0% | 66.3% | 69.5% | 69.8% | · | |
| Operating Margin | 18.6% | -19.1% | -23.7% | -91.2% | -2.7% | 17.9% | 27.8% | 26.5% | 22.0% | 24.5% | 27.6% | · | |
| Net Margin | 19.6% | -28.0% | -25.8% | -96.1% | 16.8% | 20.2% | 28.3% | 24.8% | 26.4% | 19.3% | 20.8% | · | |
| Pretax Margin | 25.0% | -27.0% | -24.8% | -94.6% | 19.5% | 26.4% | 31.6% | 26.8% | 37.9% | 23.4% | 26.3% | · | |
| EBITDA Margin | 24.8% | -11.0% | -14.1% | -82.6% | 2.8% | 23.7% | 33.1% | 31.9% | 27.7% | 30.4% | 27.6% | · | |
| ROA | 13.1% | -14.9% | -10.4% | -32.1% | 6.7% | 8.8% | 14.0% | 13.5% | 15.2% | 11.6% | 13.1% | · | |
| ROE | 34.1% | -54.4% | -19.9% | -66.1% | 7.1% | 14.0% | 22.1% | 25.4% | 29.4% | 22.9% | 27.9% | · | |
| ROIC | 19.6% | -30.1% | -19.3% | -59.8% | -0.99% | 7.6% | 15.2% | 13.4% | 10.0% | 13.8% | 16.4% | · |
Liquidez y Solvencia 5
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 1.8 | 1.7 | 1.3 | 2.5 | 3.6 | 6.7 | 2.5 | 4.0 | 3.3 | 3.4 | · | |
| Quick Ratio | 0.7 | 0.5 | 0.5 | 0.3 | 0.7 | 1.7 | 2.9 | 2.2 | 3.4 | 2.8 | 2.9 | · | |
| Debt / Equity | 0.2 | 0.2 | 0.0 | 0.1 | · | 0.3 | 0.2 | 0.5 | 0.4 | 0.5 | 0.6 | · | |
| LT Debt / Equity | · | · | · | · | · | 0.1 | 0.2 | 0.2 | 0.4 | 0.5 | 0.5 | · | |
| Interest Coverage | · | · | -13.9 | -160.7 | -2.0 | 11.8 | 18.9 | 15.5 | 16.4 | 17.7 | 14.5 | · |
Eficiencia 3
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.5 | 0.4 | 0.3 | 0.4 | 0.4 | 0.5 | 0.5 | 0.6 | 0.6 | 0.6 | · | |
| Inventory Turnover | 2.7 | 2.7 | 3.0 | 3.2 | 3.4 | 2.8 | 2.9 | 2.9 | 2.9 | 2.6 | 2.9 | · | |
| Receivables Turnover | 5.5 | 6.0 | 6.4 | 7.0 | 8.0 | 6.1 | 6.5 | 7.2 | 6.9 | 6.3 | 6.6 | · |
Tasas de Crecimiento 7
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -0.66% | -2.9% | -1.8% | 1.3% | 39.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -1.8% | -1.1% | 11.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 6.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | · | · | 13.3% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 4.1% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | · | · | 16.2% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 5.3% | · | · | · | · | · | · | · | · | · | · | · |
Valoración (TTM) 14
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.34B | $4.37B | $4.50B | $4.58B | $4.53B | $3.24B | $3.54B | $3.33B | $2.75B | $2.40B | $2.22B | $1.86B | |
| Net Income TTM | $850M | $-1.22B | $-1.16B | $-4.40B | $762M | $656M | $1.00B | $826M | $726M | $463M | $462M | $353M | |
| Market Cap | $20.65B | $21.51B | $21.54B | $31.08B | $58.10B | $52.55B | $47.52B | $42.65B | $31.24B | $18.21B | $27.37B | · | |
| Enterprise Value | · | · | · | · | · | · | · | $41.13B | $30.29B | $17.70B | $27.07B | · | |
| P/E | 24.8 | -17.6 | -18.5 | -7.0 | 73.4 | 80.9 | 48.0 | 52.2 | 43.2 | 40.6 | 60.2 | 77.2 | |
| P/S | 4.8 | 4.9 | 4.8 | 6.8 | 12.8 | 16.2 | 13.4 | 12.8 | 11.4 | 7.6 | 12.3 | · | |
| P/B | 7.6 | 9.1 | 3.7 | 4.7 | 5.4 | 11.2 | 10.3 | 11.3 | 11.4 | 8.3 | 14.8 | · | |
| P / Tangible Book | 14.7 | 22.3 | 104.0 | 414.4 | 154.1 | 14.4 | · | · | · | · | · | · | |
| P / Cash Flow | 19.1 | 25.7 | 45.1 | 79.3 | 106.6 | 48.7 | 45.2 | 37.3 | 35.7 | 26.5 | 41.5 | · | |
| P / FCF | 22.2 | 30.3 | 76.1 | 293.2 | 172.4 | 59.0 | 56.4 | 50.4 | 55.3 | 42.6 | 53.0 | · | |
| EV / EBITDA | · | · | · | · | · | · | · | 38.7 | 39.8 | 24.3 | 44.2 | · | |
| EV / FCF | · | · | · | · | · | · | · | 48.6 | 53.6 | 41.4 | 52.4 | · | |
| EV / Revenue | · | · | · | · | · | · | · | 12.3 | 11.0 | 7.4 | 12.2 | · | |
| Earnings Yield | 4.0% | -5.7% | -5.4% | -14.2% | 1.4% | 1.2% | 2.1% | 1.9% | 2.3% | 2.5% | 1.7% | 1.3% |
Estado de resultados 18
| Métrica | Tendencia | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.16B | $1.09B | $1.16B | $1.08B | $1.06B | $1.04B | $1.10B | $1.08B | $1.11B | $1.08B | $1.02B | $1.18B | $1.09B | $1.11B | |
| Cost of Revenue | $389M | $370M | $400M | $351M | $364M | $358M | $376M | $335M | $391M | $409M | $476M | $444M | $432M | $480M | |
| Gross Profit | $770M | $721M | $759M | $733M | $695M | $683M | $728M | $745M | $721M | $667M | $542M | $732M | $655M | $626M | |
| R&D Expense | $252M | $240M | $239M | $229M | $247M | $252M | $252M | $253M | $325M | $339M | $332M | $358M | $341M | $474M | |
| SG&A Expense | $273M | $272M | $308M | $277M | $234M | $267M | $267M | $239M | $147M | $439M | $464M | $462M | $378M | $205M | |
| Operating Expenses | $525M | $512M | $557M | $506M | $481M | $519M | $554M | $4M | $2.36B | $778M | $1.64B | $820M | $719M | $4.60B | |
| Operating Income | $245M | $209M | $202M | $227M | $214M | $164M | $174M | $741M | $-1.64B | $-111M | $-1.10B | $-88M | $-64M | $-3.98B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $18M | · | $19M | $20M | · | |
| Interest Income | $8M | $11M | $10M | $9M | $10M | $11M | $10M | $11M | $13M | $12M | $24M | $17M | $17M | $9M | |
| Other Non-op | $31M | $-39M | $192M | $9M | $107M | $32M | $28M | $4M | $-332M | $8M | $19M | $1M | $-11M | $-45M | |
| Pretax Income | $260M | $157M | $378M | $220M | $306M | $182M | $186M | $720M | $-1.98B | $-109M | $-1.09B | $-89M | $-78M | $-4.01B | |
| Income Tax | $53M | $23M | $44M | $70M | $71M | $51M | $0 | $15M | $12M | $17M | $-74M | $145M | $-81M | $94M | |
| Net Income | $207M | $134M | $334M | $150M | $235M | $131M | $186M | $705M | $-1.99B | $-126M | $-791M | $-234M | $3M | $-4.10B | |
| EPS (Basic) | $1.37 | $0.88 | $2.17 | $0.98 | $1.49 | $0.83 | $1.15 | $4.43 | $-12.48 | $-0.79 | $-6.43 | $-1.48 | $0.02 | $-26.16 | |
| EPS (Diluted) | $1.35 | $0.87 | $2.16 | $0.98 | $1.49 | $0.82 | $1.16 | $4.42 | $-12.48 | $-0.79 | $-6.43 | $-1.48 | $0.02 | $-26.15 | |
| Shares (Basic) | 151,000,000 | 153,000,000 | -314,000,000 | 153,000,000 | 157,000,000 | 159,000,000 | -318,000,000 | 159,000,000 | 159,000,000 | 159,000,000 | -315,000,000 | 158,000,000 | 158,000,000 | -303,000,000 | |
| Shares (Diluted) | 153,000,000 | 154,000,000 | -314,000,000 | 154,000,000 | 157,000,000 | 159,000,000 | -319,000,000 | 160,000,000 | 159,000,000 | 159,000,000 | -317,000,000 | 158,000,000 | 158,000,000 | -306,000,000 | |
| EBITDA | $245M | $209M | · | $294M | $282M | $233M | · | $741M | $-1.64B | $-111M | · | $-88M | $-64M | · |
Balance general 27
| Métrica | Tendencia | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Short-term Investments | $128M | $66M | $215M | $228M | $221M | $124M | $93M | $70M | $74M | · | · | $6M | $24M | · | |
| Receivables | $764M | $738M | $854M | $729M | $701M | $699M | $735M | $699M | $641M | $635M | · | $741M | $665M | · | |
| Inventory | $629M | $611M | $564M | $590M | $575M | $537M | $547M | $574M | $561M | $584M | · | $617M | $586M | · | |
| Prepaid Expense | $273M | $234M | $238M | $199M | $210M | $200M | $244M | $161M | $263M | $256M | · | $306M | $403M | · | |
| Current Assets | $2.83B | $2.74B | $3.29B | $2.80B | $2.64B | $2.67B | $2.75B | $2.37B | $2.46B | $2.58B | · | $3.22B | $3.17B | · | |
| PP&E (Net) | $745M | $755M | $759M | $748M | $764M | $782M | $815M | $832M | $859M | $964M | · | $1.07B | $1.08B | · | |
| PP&E (Gross) | · | · | $2.12B | · | · | · | $2.07B | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $1.36B | · | · | · | $1.25B | · | · | · | · | · | · | · | |
| Goodwill | $1.28B | $1.28B | $1.11B | $1.11B | $1.11B | $1.11B | $1.11B | $1.11B | $1.08B | $2.54B | $2.54B | $3.24B | $3.24B | $3.24B | |
| Intangibles | $410M | $430M | $210M | $225M | $238M | $278M | $295M | $305M | $278M | $2.94B | · | $3.19B | $3.24B | · | |
| Other Non-current Assets | $576M | $523M | $449M | $423M | $400M | $373M | $348M | $321M | $314M | $458M | · | $417M | $423M | · | |
| Total Assets | $6.65B | $6.56B | $6.64B | $6.18B | $6.09B | $6.18B | $6.30B | $6.01B | $6.08B | $10.04B | · | $11.77B | $11.81B | · | |
| Accounts Payable | $230M | $218M | $240M | $218M | $200M | $207M | $221M | $191M | $199M | $201M | · | $244M | $242M | · | |
| Accrued Liabilities | $848M | $849M | $846M | $746M | $762M | $734M | $827M | $784M | $1.26B | $1.27B | · | $1.31B | $1.24B | · | |
| Short-term Debt | $500M | $499M | $499M | $998M | $499M | $499M | $499M | · | $744M | · | · | $0 | $0 | · | |
| Current Liabilities | $1.58B | $1.57B | $1.58B | $1.96B | $1.46B | $1.44B | $1.55B | $975M | $2.21B | $1.47B | · | $2.30B | $2.23B | · | |
| Capital Leases | $454M | $475M | $486M | $506M | $528M | $539M | $554M | $613M | $616M | $700M | · | $726M | $747M | · | |
| Other Non-current Liabilities | $289M | $352M | $360M | $334M | $348M | $344M | $339M | $313M | $331M | $642M | · | $702M | $654M | · | |
| Total Debt | $500M | $499M | · | $998M | $499M | $499M | · | · | $744M | · | · | · | · | · | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | · | |
| Paid-in Capital | $7.93B | $7.86B | $7.82B | $7.76B | $7.68B | $7.61B | $7.53B | $7.45B | $7.35B | $9.66B | · | $9.40B | $9.31B | · | |
| Retained Earnings | $-51M | $-258M | $-392M | $-726M | $-876M | $-1.11B | $-1.24B | $-1.43B | $-2.13B | $-145M | · | $911M | $1.15B | · | |
| Treasury Stock | $5.05B | $4.93B | $4.70B | $4.64B | $4.52B | $4.14B | $3.93B | $3.89B | $3.79B | $3.79B | · | $3.77B | $3.76B | · | |
| AOCI | $8M | $1M | $-10M | $-12M | $-21M | $8M | $22M | $-5M | $14M | $12M | · | $12M | $-1M | · | |
| Stockholders' Equity | $2.84B | $2.68B | $2.72B | $2.38B | $2.26B | $2.37B | $2.37B | $2.12B | $1.44B | $5.73B | $5.75B | $6.55B | $6.69B | $6.60B | |
| Liabilities + Equity | $6.65B | $6.56B | $6.64B | $6.18B | $6.09B | $6.18B | $6.30B | $6.01B | $6.08B | $10.04B | · | $11.77B | $11.81B | · | |
| Shares Outstanding | 201,000,000 | 201,000,000 | 153,000,000 | 201,000,000 | 201,000,000 | 201,000,000 | 159,000,000 | 199,000,000 | 199,000,000 | 199,000,000 | 199,000,000 | 198,000,000 | 198,000,000 | 198,000,000 |
Flujo de Efectivo 17
| Métrica | Tendencia | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | $66M | $67M | $68M | $69M | $71M | $70M | $105M | $108M | · | · | · | $232M | |
| Stock-based Comp | $73M | $60M | $63M | $70M | $69M | $73M | $79M | $83M | $112M | $96M | $94M | · | $93M | $100M | |
| Amort. of Intangibles | $19M | $18M | $16M | $17M | $17M | $17M | $17M | $17M | $47M | $49M | $57M | $49M | $50M | $112M | |
| Restructuring | · | · | $6M | $2M | $8M | $31M | $2M | $6M | $4M | $4M | · | $26M | · | · | |
| Other Non-cash | · | · | · | · | · | $-33M | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $201M | $289M | $321M | $284M | $234M | $240M | $364M | $316M | $80M | $77M | $224M | · | $10M | $147M | |
| CapEx | $40M | $38M | $55M | $31M | $30M | $32M | $29M | $32M | $31M | $36M | $51M | · | $52M | $88M | |
| Investing Cash Flow | $-122M | $-366M | $108M | $-51M | $-49M | $-63M | $-48M | $-41M | $-41M | $-48M | $-85M | · | $-56M | $-102M | |
| Debt Issued | · | · | $495M | · | · | · | $0 | · | · | · | · | · | · | $3M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | $-500M | · | |
| Stock Issued | $0 | $24M | $0 | $16M | $1M | $27M | $0 | $20M | $0 | $36M | $0 | · | $37M | $0 | |
| Stock Repurchased | $128M | $242M | $42M | $130M | $370M | $200M | $17M | $99M | $0 | $0 | $0 | · | · | $0 | |
| Net Stock Activity | · | $-218M | · | · | · | $-173M | · | · | · | $36M | · | · | $37M | · | |
| Financing Cash Flow | $-129M | $-251M | $-63M | $-115M | $-371M | $-195M | $-47M | $-332M | $-226M | $35M | $-27M | · | $-473M | $956M | |
| Net Change in Cash | $-49M | $-329M | $368M | $116M | $-179M | $-14M | $258M | $-51M | $-188M | $60M | $121M | · | $-517M | $1.01B | |
| Free Cash Flow | · | $251M | · | · | · | $208M | · | · | · | $41M | · | · | $-42M | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $20M | · | · | $-41M | · |
Rentabilidad 8
| Métrica | Tendencia | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 66.4% | 66.1% | · | 67.6% | 65.6% | 65.6% | · | 69.0% | 64.8% | 62.0% | · | 62.2% | 60.3% | · | |
| Operating Margin | 21.1% | 19.2% | · | 20.9% | 20.2% | 15.8% | · | 68.6% | -147.2% | -10.3% | · | -7.5% | -5.9% | · | |
| Net Margin | 17.9% | 12.3% | · | 13.8% | 22.2% | 12.6% | · | 65.3% | -178.8% | -11.7% | · | -19.9% | 0.28% | · | |
| Pretax Margin | 22.4% | 14.4% | · | 20.3% | 28.9% | 17.5% | · | 66.7% | -177.7% | -10.1% | · | -7.6% | -7.2% | · | |
| EBITDA Margin | 21.1% | 19.2% | · | 27.1% | 26.6% | 22.4% | · | 68.6% | -147.2% | -10.3% | · | -7.5% | -5.9% | · | |
| ROA | 3.2% | 2.1% | · | 2.5% | 3.9% | 1.6% | · | 8.7% | -22.3% | -1.1% | · | · | · | · | |
| ROE | 8.1% | 5.3% | · | 6.7% | 12.7% | 3.2% | · | 17.6% | -49.8% | -2.0% | · | · | · | · | |
| ROIC | 5.8% | 5.6% | · | 4.6% | 6.0% | 4.1% | · | 34.1% | -75.5% | -2.2% | · | · | · | · |
Liquidez y Solvencia 4
| Métrica | Tendencia | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | 1.7 | · | 1.4 | 1.8 | 1.9 | · | 2.4 | 1.1 | 1.8 | · | · | · | · | |
| Quick Ratio | 0.6 | 0.5 | · | 0.5 | 0.6 | 0.6 | · | 0.8 | 0.3 | 0.4 | · | · | · | · | |
| Debt / Equity | 0.2 | 0.2 | · | 0.4 | 0.2 | 0.2 | · | · | 0.5 | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -6.2 | · | -4.6 | -3.2 | · |
Eficiencia 3
| Métrica | Tendencia | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | · | · | · | |
| Inventory Turnover | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | 0.7 | 0.7 | · | · | · | · | |
| Receivables Turnover | 1.6 | 1.5 | · | 1.5 | 1.6 | 1.6 | · | 1.6 | 1.6 | 1.7 | · | · | · | · |
Valoración (TTM) 10
| Métrica | Tendencia | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.39B | $4.28B | · | $4.26B | $4.29B | $4.31B | · | $4.39B | $4.48B | $4.46B | · | $4.49B | $4.48B | · | |
| Net Income TTM | $825M | $853M | · | $702M | $1.26B | $-966M | · | $-1.58B | $-3.04B | $-1.29B | · | $-4.19B | · | · | |
| Market Cap | $35.49B | $23.65B | · | $18.43B | $19.05B | $16.08B | · | $25.89B | $20.77B | $26.58B | · | · | · | · | |
| P/E | 37.6 | 28.3 | · | 11.9 | -16.5 | -10.0 | · | -9.6 | -5.3 | -19.0 | · | -3.6 | -4.4 | · | |
| P/S | 8.1 | 5.5 | · | 4.3 | 4.4 | 3.7 | · | 5.9 | 4.6 | 6.0 | · | · | · | · | |
| P/B | 12.5 | 8.8 | · | 7.7 | 8.4 | 6.8 | · | 12.2 | 14.5 | 4.6 | · | · | · | · | |
| P / Tangible Book | 31.0 | 24.6 | · | 17.7 | 21.0 | 16.5 | · | 36.6 | 262.9 | 106.8 | · | · | · | · | |
| P / Cash Flow | · | 81.8 | · | · | · | 67.0 | · | · | · | 345.2 | · | · | · | · | |
| P / FCF | · | 94.2 | · | · | · | 77.3 | · | · | · | 648.4 | · | · | · | · | |
| Earnings Yield | 2.7% | 3.5% | · | 8.4% | -6.1% | -10.0% | · | -10.5% | -18.7% | -5.3% | · | -27.4% | -22.9% | · |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-28 | 2024-12-29 | 2023-12-31 | 2023-01-01 | 2022-01-02 | |
|---|---|---|---|---|---|
| Ingresos | $4.34B | $4.37B | $4.50B | $4.58B | $4.53B |
| Margen Bruto % | 66.1% | 65.4% | 60.9% | 64.8% | 69.7% |
| Margen Operativo % | 18.6% | -19.1% | -23.7% | -91.2% | -2.7% |
| Beneficio neto | $850M | $-1.22B | $-1.16B | $-4.40B | $762M |
| EPS Diluido | $5.45 | $-7.69 | $-7.34 | $-28.00 | $5.04 |
Balance general
| 2025-12-28 | 2024-12-29 | 2023-12-31 | 2023-01-01 | 2022-01-02 | |
|---|---|---|---|---|---|
| Deuda / Patrimonio | 0.2 | 0.2 | 0.0 | 0.1 | — |
| Ratio corriente | 2.1 | 1.8 | 1.7 | 1.3 | 2.5 |
| Ratio Rápido | 0.7 | 0.5 | 0.5 | 0.3 | 0.7 |
Flujo de Efectivo
| 2025-12-28 | 2024-12-29 | 2023-12-31 | 2023-01-01 | 2022-01-02 | |
|---|---|---|---|---|---|
| Flujo de caja libre | $931M | $709M | $283M | $106M | $337M |
Últimas noticias Noticias recientes que mencionan a esta empresa
Señales de trading Señales recientes de compra/venta con precio de entrada y ratio riesgo/recompensa
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 1 008 declarantes · $18.4B total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 159 (+41 vs trimestre anterior) | 60 (-33 vs trimestre anterior) | 300 (+17 vs trimestre anterior) | 326 (+4 vs trimestre anterior) | -2.2M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| Capital World Investors | $2 712 230 480 | 15 425 298 | 14,78% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1 165 253 015 | 6 627 157 | 6,35% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $1 158 286 103 | 6 587 534 | 6,31% | Acciones |
| STATE STREET CORP | $1 144 176 449 | 6 507 288 | 6,23% | Acciones |
| WCM INVESTMENT MANAGEMENT, LLC | $1 124 033 551 | 6 206 701 | 6,12% | Acciones |
| PRIMECAP MANAGEMENT CO/CA/ | $617 980 735 | 3 514 649 | 3,37% | Acciones |
| FMR LLC | $523 532 529 | 2 977 492 | 2,85% | Acciones |
| Corvex Management LP | $497 695 958 | 2 830 552 | 2,71% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $412 561 415 | 2 354 283 | 2,25% | Acciones |
| LOOMIS SAYLES & CO L P | $298 854 639 | 1 699 679 | 1,63% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $284 828 951 | 1 619 911 | 1,55% | Acciones |
| JANUS HENDERSON GROUP PLC | $246 405 738 | 1 999 073 | 1,34% | Acciones |
| Sessa Capital IM, L.P. | $196 643 700 | 1 118 374 | 1,07% | Acciones |
| AMERIPRISE FINANCIAL INC | $191 377 137 | 1 088 353 | 1,04% | Acciones |
| ARK Investment Management LLC | $183 744 158 | 1 045 010 | 1,00% | Acciones |
| Senvest Management, LLC | $177 362 886 | 1 008 718 | 0,97% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $167 266 376 | 951 296 | 0,91% | Acciones |
| Sumitomo Mitsui Trust Group, Inc. | $167 050 984 | 950 071 | 0,91% | Acciones |
| FIRST TRUST ADVISORS LP | $159 563 763 | 907 489 | 0,87% | Acciones |
| PointState Capital LP | $151 602 384 | 862 210 | 0,83% | Acciones |
| LETKO, BROSSEAU & ASSOCIATES INC | $145 990 418 | 830 293 | 0,80% | Acciones |
| NORGES BANK | $145 424 246 | 827 073 | 0,79% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $145 348 463 | 826 642 | 0,79% | Acciones |
| EDMOND DE ROTHSCHILD HOLDING S.A. | $129 791 552 | 738 165 | 0,71% | Acciones |
| GUARDCAP ASSET MANAGEMENT Ltd | $128 748 557 | 740 132 | 0,70% | Acciones |
| Chevy Chase Trust Holdings, LLC | $127 952 370 | 727 705 | 0,70% | Acciones |
| Quantinno Capital Management LP | $117 941 015 | 670 767 | 0,64% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $111 675 435 | 635 133 | 0,61% | Acciones |
| Amova Asset Management Americas, Inc. | $108 658 017 | 617 972 | 0,59% | Acciones |
| ALLIANCEBERNSTEIN L.P. | $108 597 114 | 881 041 | 0,59% | Acciones |
| Alyeska Investment Group, L.P. | $102 285 586 | 581 730 | 0,56% | Acciones |
| RHUMBLINE ADVISERS | $98 590 641 | 560 716 | 0,54% | Acciones |
| BROWN ADVISORY INC | $96 835 682 | 550 735 | 0,53% | Acciones |
| Stephens Investment Management Group LLC | $94 583 529 | 537 926 | 0,52% | Acciones |
| Casdin Capital, LLC | $93 189 900 | 530 000 | 0,51% | Acciones |
| NORDEA INVESTMENT MANAGEMENT AB | $90 531 934 | 515 499 | 0,49% | Acciones |
| Caisse de depot et placement du Quebec | $86 532 800 | 492 139 | 0,47% | Acciones |
| GOLDMAN SACHS GROUP INC | $84 217 839 | 478 973 | 0,46% | Acciones |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $82 394 290 | 468 602 | 0,45% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $82 176 517 | 467 365 | 0,45% | Acciones |
| Spyglass Capital Management LLC | $80 665 002 | 458 767 | 0,44% | Acciones |
| BlackRock, Inc. | $77 542 612 | 441 009 | 0,42% | Acciones |
| Swiss National Bank | $73 918 932 | 420 400 | 0,40% | Acciones |
| ENVESTNET ASSET MANAGEMENT INC | $72 810 204 | 414 094 | 0,40% | Acciones |
| M&G PLC | $71 140 608 | 404 208 | 0,39% | Acciones |
| Southpoint Capital Advisors LP | $70 332 000 | 400 000 | 0,38% | Acciones |
| National Pension Service | $65 031 780 | 369 856 | 0,35% | Acciones |
| KEYBANK NATIONAL ASSOCIATION/OH | $64 398 474 | 366 254 | 0,35% | Acciones |
| LMR Partners LLP | $62 631 877 | 356 207 | 0,34% | Acciones |
| Gotham Asset Management, LLC | $62 627 657 | 356 183 | 0,34% | Acciones |
| Patient Capital Management, LLC | $60 716 695 | 345 314 | 0,33% | Acciones |
| BANK OF AMERICA CORP /DE/ | $59 969 108 | 341 063 | 0,33% | Acciones |
| California Public Employees Retirement System | $59 582 457 | 338 864 | 0,32% | Acciones |
| PANAGORA ASSET MANAGEMENT INC | $58 761 155 | 334 193 | 0,32% | Acciones |
| BAILLIE GIFFORD & CO | $57 855 807 | 329 044 | 0,32% | Acciones |
| Douglas Lane & Associates, LLC | $57 088 338 | 324 679 | 0,31% | Acciones |
| VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. | $55 453 265 | 315 380 | 0,30% | Acciones |
| Robeco Institutional Asset Management B.V. | $54 117 836 | 307 785 | 0,29% | Acciones |
| Diamond Hill Capital Management, LLC (Investment Advisor) | $53 037 713 | 301 642 | 0,29% | Acciones |
| VANGUARD ASSET MANAGEMENT, Ltd | $51 879 696 | 295 056 | 0,28% | Acciones |
| Ilex Capital Partners (UK) LLP | $50 837 904 | 289 131 | 0,28% | Acciones |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $49 655 000 | 282 402 | 0,27% | Acciones |
| Pictet Asset Management Holding SA | $48 335 824 | 268 581 | 0,26% | Acciones |
| TEACHER RETIREMENT SYSTEM OF TEXAS | $48 163 179 | 273 919 | 0,26% | Acciones |
| RAYMOND JAMES FINANCIAL INC | $47 981 443 | 272 885 | 0,26% | Acciones |
| IEQ CAPITAL, LLC | $47 110 622 | 267 932 | 0,26% | Acciones |
| JENNISON ASSOCIATES LLC | $46 171 981 | 262 594 | 0,25% | Acciones |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $45 645 123 | 348 011 | 0,25% | Acciones |
| ROYAL BANK OF CANADA | $43 456 000 | 247 148 | 0,24% | Acciones |
| ASR Vermogensbeheer N.V. | $43 316 775 | 246 356 | 0,24% | Acciones |
| AustralianSuper Pty Ltd | $41 627 928 | 236 751 | 0,23% | Acciones |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $41 306 863 | 234 925 | 0,23% | Acciones |
| BAMCO INC /NY/ | $39 929 938 | 227 094 | 0,22% | Acciones |
| Legal & General Group Plc | $39 368 159 | 223 899 | 0,21% | Acciones |
| Cannell & Spears LLC | $36 928 050 | 210 021 | 0,20% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $33 545 023 | 190 781 | 0,18% | Acciones |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $33 236 344 | 189 272 | 0,18% | Acciones |
| NORTH STAR ASSET MANAGEMENT INC | $33 038 984 | 187 903 | 0,18% | Acciones |
| Eagle Health Investments LP | $32 952 828 | 187 413 | 0,18% | Acciones |
| VANGUARD GROUP INC | $32 906 339 | 250 887 | 0,18% | Acciones |
| MORGAN STANLEY | $32 416 825 | 184 364 | 0,18% | Acciones |
| Baird Financial Group, Inc. | $31 122 437 | 177 003 | 0,17% | Acciones |
| BARCLAYS PLC | $31 054 392 | 176 616 | 0,17% | Acciones |
| Howard Capital Management, LLC | $31 000 587 | 176 310 | 0,17% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $30 910 914 | 175 800 | 0,17% | Opción de compra |
| Mitsubishi UFJ Asset Management Co., Ltd. | $30 501 230 | 173 470 | 0,17% | Acciones |
| PFA Pension, Forsikringsaktieselskab | $30 069 940 | 171 017 | 0,16% | Acciones |
| OSTRUM ASSET MANAGEMENT | $29 637 026 | 168 555 | 0,16% | Acciones |
| Artisan Partners Limited Partnership | $29 485 109 | 167 691 | 0,16% | Acciones |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $29 159 125 | 236 566 | 0,16% | Acciones |
| Mitsubishi UFJ Trust & Banking Corp | $29 130 459 | 165 674 | 0,16% | Acciones |
| CANADA PENSION PLAN INVESTMENT BOARD | $28 451 052 | 161 810 | 0,16% | Acciones |
| CIBC Private Wealth Group LLC | $28 430 314 | 299 361 | 0,15% | Acciones |
| Hardman Johnston Global Advisors LLC | $28 131 745 | 159 994 | 0,15% | Acciones |
| Retirement Systems of Alabama | $27 515 109 | 156 487 | 0,15% | Acciones |
| PEAK6 LLC | $25 653 597 | 145 900 | 0,14% | Opción de compra |
| Assenagon Asset Management S.A. | $24 616 727 | 140 003 | 0,13% | Acciones |
| Candriam S.C.A. | $24 288 272 | 138 268 | 0,13% | Acciones |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $24 059 346 | 136 833 | 0,13% | Acciones |
| Capital Investment Services of America, Inc. | $22 808 316 | 129 718 | 0,12% | Acciones |
Informantes de la empresa 88 insiders · 50 directivos · 30 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Jacob Thaysen | Chief Executive Officer | 5 de marzo de 2026 A | 109 073 | 0 | 0 | $0 |
| Francis A Desouza | President and CEO | 1 de marzo de 2023 A | 120 992 | 0 | 0 | $0 |
| Ankur Dhingra | SVP, Chief Financial Officer | 5 de marzo de 2026 A | 34 264 | 0 | 0 | $0 |
| Joydeep Goswami | SVP, Chief Financial Officer | 5 de marzo de 2024 A | 24 478 | 0 | 0 | $0 |
| Sam Samad | SVP and CFO | 1 de marzo de 2022 A | 11 297 | 0 | 0 | $0 |
| Timothy M Kish | VP Finance & CFO | 2 de marzo de 2005 A | — | 0 | 0 | $0 |
| John R Stuelpnagel | Sr VP and COO | 27 de marzo de 2008 M | 337 836 | 0 | 0 | $0 |
| Christensen Jakob Wedel | SVP, Strategy/Corp Development | 18 de agosto de 2026 S | 14 023 | 0 | 3 | $-366 137 |
| Scott M Davies | Chief Legal Officer | 30 de julio de 2026 S | 20 338 | 0 | 5 | $-531 273 |
| Patricia Leckman | SVP, Chief People Officer | 5 de junio de 2026 S | 21 259 | 0 | 9 | $-529 720 |
| Scott D Ericksen | VP, Chief Accounting Officer | 29 de mayo de 2026 S | 14 446 | 0 | 2 | $-305 150 |
| Steven Barnard | SVP, Chief Technology Officer | 5 de marzo de 2026 A | 41 335 | 0 | 0 | $0 |
| Kevin Carl Pegels | Chief of Global Operations | 5 de marzo de 2026 A | 29 038 | 0 | 0 | $0 |
| Everett Cunningham | SVP, Chief Commercial Officer | 5 de julio de 2025 F | 41 942 | 0 | 0 | $0 |
| Carissa Rollins | SVP, Chief Information Officer | 5 de abril de 2025 F | 18 447 | 0 | 0 | $0 |
| Charles Dadswell | SVP, General Counsel | 13 de septiembre de 2024 D | 20 586 | 0 | 0 | $0 |
| Kathryne Gambrell Reeves | SVP, Chief Marketing Officer | 5 de marzo de 2024 A | 17 965 | 0 | 0 | $0 |
| Aimee L Hoyt | SVP, Chief People Officer | 7 de noviembre de 2023 S | 8 314 | 0 | 0 | $0 |
| Susan H Tousi | SVP, Chief Commercial Officer | 5 de noviembre de 2023 F | 43 743 | 0 | 0 | $0 |
| Alexander Aravanis | SVP, Chief Technology Officer | 5 de julio de 2023 F | 12 587 | 0 | 0 | $0 |
| John Edward Frank | Chief Public Affairs Officer | 5 de mayo de 2023 F | 9 166 | 0 | 0 | $0 |
| Phillip G. Febbo | SVP Chief Medical Officer | 1 de marzo de 2023 A | 14 786 | 0 | 0 | $0 |
| Jose Torres | VP, Chief Accounting Officer | 5 de mayo de 2022 F | 1 748 | 0 | 0 | $0 |
| Karen K Mcginnis | VP, Chief Accounting Officer | 18 de febrero de 2021 S | 1 538 | 0 | 0 | $0 |
| Robert P Ragusa | SVP, Global Quality & Ops | 17 de febrero de 2021 M | 9 617 | 0 | 0 | $0 |
| Mostafa Ronaghi | SVP, Entrepreneurial Devlopmt | 10 de diciembre de 2020 S | 80 162 | 0 | 0 | $0 |
| Mark Van Oene | SVP Chief Commercial Officer | 5 de noviembre de 2020 F | 16 575 | 0 | 0 | $0 |
| Omead Ostadan | SVP Mktg, Prod & Strat Plan | 11 de mayo de 2020 S | 17 172 | 0 | 0 | $0 |
| Malcolm Garret Hampton | SVP Clinical Genomics Group | 9 de enero de 2020 F | 6 598 | 0 | 0 | $0 |
| Marc Stapley | EVP Strategy & Corp Developmt | 6 de diciembre de 2018 S | 6 957 | 0 | 0 | $0 |
| Michel Bouchard | Chief Accounting Officer | 6 de noviembre de 2017 F | 9 538 | 0 | 0 | $0 |
| Christian O Henry | EVP & Chief Commercial Officer | 30 de enero de 2017 F | 17 531 | 0 | 0 | $0 |
| Tristan Orpin | EVP Clinical Genomics | 7 de noviembre de 2016 F | 118 259 | 0 | 0 | $0 |
| Nicholas Naclerio | Sr VP, Corporate Development | 21 de marzo de 2016 S | 30 020 | 0 | 0 | $0 |
| Richard Klausner | Sr VP, Chief Medical Officer | 29 de enero de 2016 F | 22 847 | 0 | 0 | $0 |
| Gregory Heath | Sr VP & General Manager | 17 de diciembre de 2013 M | 26 740 | 0 | 0 | $0 |
| Mark L Lewis | Sr VP & General Manager | 1 de noviembre de 2013 M | 44 837 | 0 | 0 | $0 |
| Matthew L. Posard | Sr VP & General Manager | 30 de mayo de 2013 M | 30 858 | 0 | 0 | $0 |
| Christian Cabou | Sr VP & General Counsel | 23 de abril de 2013 M | 45 553 | 0 | 0 | $0 |
| Joel Mccomb | Sr VP & General Manager | 28 de enero de 2010 F | 6 595 | 0 | 0 | $0 |
| John West | Sr. VP & GM DNA Sequencing | 8 de noviembre de 2007 M | 82 062 | 0 | 0 | $0 |
| Arthur Holden | Sr VP Corp & Market Dev | 25 de enero de 2007 A | — | 0 | 0 | $0 |
| David L Barker | Chief Scientific Officer | 29 de noviembre de 2005 S | 137 636 | 0 | 0 | $0 |
| Alan Kersey | V.P. & Site Manager | 31 de agosto de 2005 S | 48 582 | 0 | 0 | $0 |
| Robert C Kain | Vice President Engineering | 23 de agosto de 2005 S | 125 311 | 0 | 0 | $0 |
| Kirk Malloy | V.P. of Customer Solutions | 9 de mayo de 2005 A | — | 0 | 0 | $0 |
| David C Douglas | Vice President Manufacturing | 2 de mayo de 2005 S | 0 | 0 | 0 | $0 |
| Scott D Kahn | Chief Information Officer | 6 de abril de 2005 A | — | 0 | 0 | $0 |
| Arnold R Oliphant | VP Scientific Operations | 28 de febrero de 2005 M | 0 | 0 | 0 | $0 |
| Noemi C Espinosa | VP Intellectual Property | 25 de febrero de 2005 A | 204 704 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 1 tenencia
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Illumina, Inc. ×2 presentaciones | 5 de febrero de 2007 | — | Presentación inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 171 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| EKG · First Trust Exchange-Traded Fund II | 5,00% | 801 NS | 30 de junio de 2026 | N-PORT |
| GNOM · Global X Funds | 4,82% | 16 512 NS | 31 de mayo de 2026 | N-PORT |
| XMHQ · Invesco Exchange-Traded Fund Trust | 4,24% | 1 121 719 SH | 21 de agosto de 2026 | Diario |
| ARKG · ARK ETF Trust | 4,03% | 392 835 NS | 30 de abril de 2026 | N-PORT |
| FBT · First Trust Exchange-Traded Fund | 3,92% | 627 605 NS | 30 de junio de 2026 | N-PORT |
| PBE · Invesco Exchange-Traded Fund Trust | 3,38% | 63 072 SH | 21 de agosto de 2026 | Diario |
| AGIQ · Tidal Trust I | 2,49% | 1 730 NS | 31 de mayo de 2026 | N-PORT |
| IBB · iShares Trust | 2,27% | 1 128 312 SH | 21 de agosto de 2026 | Diario |
| ABOT · Abacus FCF ETF Trust | 2,09% | 727 NS | 30 de abril de 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 2,07% | 8 900 SH | 21 de agosto de 2026 | Diario |
| PTH · Invesco Exchange-Traded Fund Trust | 2,02% | 25 574 SH | 21 de agosto de 2026 | Diario |
| FTXH · First Trust Exchange-Traded Fund VI | 1,98% | 4 088 NS | 30 de junio de 2026 | N-PORT |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1,95% | 8 210 NS | 30 de abril de 2026 | N-PORT |
| MTRA · Invesco Actively Managed Exchange-T… | 1,67% | 10 711 SH | 21 de agosto de 2026 | Diario |
| ROBT · First Trust Exchange-Traded Fund VI | 1,61% | 66 999 NS | 30 de junio de 2026 | N-PORT |
| QQQJ · Invesco Exchange-Traded Fund Trust … | 1,58% | 87 868 SH | 21 de agosto de 2026 | Diario |
| THNQ · EXCHANGE TRADED CONCEPTS TRUST | 1,45% | 37 005 NS | 30 de abril de 2026 | N-PORT |
| ROBO · EXCHANGE TRADED CONCEPTS TRUST | 1,35% | 188 077 NS | 30 de abril de 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 1,34% | 92 110 NS | 30 de abril de 2026 | N-PORT |
| BIB · ProShares Trust | 1,25% | 5 653 NS | 31 de mayo de 2026 | N-PORT |
| CVAR · ETF Opportunities Trust | 1,21% | 3 691 NS | 30 de abril de 2026 | N-PORT |
| TMFX · RBB Fund, Inc. | 1,20% | 2 373 NS | 31 de mayo de 2026 | N-PORT |
| ARKK · ARK ETF Trust | 1,20% | 614 284 NS | 30 de abril de 2026 | N-PORT |
| FLCV · Federated Hermes ETF Trust | 1,14% | 6 746 NS | 31 de mayo de 2026 | N-PORT |
| ANEW · ProShares Trust | 1,06% | 502 NS | 31 de mayo de 2026 | N-PORT |
| QVMM · Invesco Exchange-Traded Fund Trust … | 1,01% | 20 494 SH | 21 de agosto de 2026 | Diario |
| LSEQ · Harbor ETF Trust | 1,01% | 1 224 NS | 30 de abril de 2026 | N-PORT |
| MIDE · DBX ETF Trust | 1,01% | 207 NS | 29 de mayo de 2026 | N-PORT |
| CGMM · Capital Group Equity ETF Trust I | 0,99% | 169 737 NS | 31 de mayo de 2026 | N-PORT |
| JOET · Virtus ETF Trust II | 0,78% | 14 553 NS | 30 de abril de 2026 | N-PORT |
| IVOG · VANGUARD ADMIRAL FUNDS | 0,75% | 80 617 SH | 19 de agosto de 2026 | Diario |
| IVOO · VANGUARD ADMIRAL FUNDS | 0,73% | 244 355 SH | 19 de agosto de 2026 | Diario |
| FLCC · Federated Hermes ETF Trust | 0,70% | 5 235 NS | 31 de mayo de 2026 | N-PORT |
| IVOV · VANGUARD ADMIRAL FUNDS | 0,70% | 59 759 SH | 19 de agosto de 2026 | Diario |
| FTKI · First Trust Exchange-Traded Fund VI | 0,67% | 908 NS | 30 de junio de 2026 | N-PORT |
| ITAN · EA Series Trust | 0,60% | 3 264 NS | 29 de mayo de 2026 | N-PORT |
| PJFM · PGIM ETF Trust | 0,59% | 600 NS | 29 de mayo de 2026 | N-PORT |
| PTMC · Pacer Funds Trust | 0,57% | 17 611 NS | 30 de abril de 2026 | N-PORT |
| MVV · ProShares Trust | 0,54% | 5 283 NS | 31 de mayo de 2026 | N-PORT |
| FTQI · First Trust Exchange-Traded Fund VI | 0,52% | 27 348 NS | 30 de junio de 2026 | N-PORT |
| IYH · iShares Trust | 0,50% | 90 658 SH | 21 de agosto de 2026 | Diario |
| FTC · First Trust Exchange-Traded AlphaDE… | 0,48% | 47 842 NS | 30 de abril de 2026 | N-PORT |
| VFQY · VANGUARD WELLINGTON FUND | 0,47% | 12 715 SH | 19 de agosto de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,39% | 448 145 SH | 19 de agosto de 2026 | Diario |
| MIDU · Direxion Shares ETF Trust | 0,38% | 2 532 NS | 30 de abril de 2026 | N-PORT |
| FLCG · Federated Hermes ETF Trust | 0,38% | 13 255 NS | 31 de mayo de 2026 | N-PORT |
| UMDD · ProShares Trust | 0,38% | 738 NS | 31 de mayo de 2026 | N-PORT |
| SMIZ · Zacks Trust | 0,35% | 5 614 NS | 31 de mayo de 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,35% | 951 944 SH | 19 de agosto de 2026 | Diario |
| PEPS · Morgan Stanley ETF Trust | 0,35% | 573 NS | 30 de junio de 2026 | N-PORT |